Mivacurium Chloride
FDA-approved product (solution, intravenous), marketed as Mivacron, Mivacron In Dextrose 5% In Plastic Container, Mivacurium Chloride.
- Registered studies
- 14
- Lab records
- 0
- Pathogens at ≥40%
- 2 of 4
Chemical structure
Existing / approved use
Documented · FDA, WHO, ChEMBLNo approved indication recorded
ChEMBL records no approved indication for Mivacurium Chloride. Its therapeutic class is shown instead.
- WHO therapeutic group
- Other quaternary ammonium compounds
- Anti-infective classification
- Not classified as an anti-infective.
Repurposing investigation
This medicine is being investigated here for AI-predicted antimicrobial activity against MRSA and E. coli. It was surfaced computationally for further investigation; it is not an established treatment for these infections.
AI-predicted activity
AI prediction · nothing measured- MRSA53.8% AI-predicted activityAt or above the ≥40% mark this site uses to surface candidates.
- E. coli40.4% AI-predicted activityAt or above the ≥40% mark this site uses to surface candidates.
- K. pneumoniae29.6% AI-predicted activityBelow the ≥40% mark this site uses to surface candidates.
- M. tuberculosis39.3% AI-predicted activityBelow the ≥40% mark this site uses to surface candidates.
A model’s estimate of laboratory activity against each pathogen species. It is not clinical effectiveness.
Evidence
Clinical and experimental
Documented evidenceClinical
14registered studies name this medicine, for any condition. See them below.
Experimental
No evidence found
No laboratory measurement against the four pathogens in the ChEMBL records loaded here.
Docking
Computational · nothing measuredDihydrofolate reductase ↗ (E. coli)
Not yet docked: queued in the docking rundetails
KPC-2 carbapenemase ↗ (K. pneumoniae)
Not yet docked: queued in the docking rundetails
Enoyl-ACP reductase (InhA) ↗ (M. tuberculosis)
Not yet docked: queued in the docking rundetails
Dihydrofolate reductase ↗ (MRSA)
Not yet docked: queued in the docking rundetails
AutoDock Vina, one experimentally solved protein per pathogen. This project’s screening target is -7.0 kcal/mol, its own mark rather than a universal cutoff. A docking score is a structural hypothesis, not proof of binding, and requires experimental validation.
Other medicines to investigate
AI prediction · nothing measuredOther repurposing candidates: approved medicines besides Mivacurium Chloride with AI-predicted activity ≥40% against the chosen pathogen, leaving out existing antimicrobials. They are computational candidates for further investigation, not alternatives and not recommendations.
Sorted by AI-predicted activity, high to low. The order is not a ranking of which medicine is better.
- FurazolidoneExisting use: Other antiinfectives and antiseptics91.4% AI-predicted activityagainst M. tuberculosisLab records exist49 registered studies
- TriflupromazineExisting use: Psychosis90.6% AI-predicted activityagainst M. tuberculosisNo documented evidence found
- ValdecoxibExisting use: Dysmenorrhea, Osteoarthritis, Rheumatic disease and 1 more88.6% AI-predicted activityagainst M. tuberculosisLab records exist31 registered studies
- CelecoxibExisting use: Ankylosing spondylitis, Cancer, Colorectal neoplasm and 15 more87.6% AI-predicted activityagainst M. tuberculosisLab records exist50+ registered studies
- Dorzolamide HydrochlorideExisting use: Glaucoma, Ocular hypertension, Open-angle glaucoma86.8% AI-predicted activityagainst M. tuberculosisLab records exist50+ registered studies
- MethazolamideExisting use: Glaucoma, Open-angle glaucoma85.6% AI-predicted activityagainst M. tuberculosisLab records exist11 registered studies
- AcetazolamideExisting use: Altitude sickness, Angle-closure glaucoma, Congestive heart failure and 5 more85.2% AI-predicted activityagainst M. tuberculosisLab records exist50+ registered studies
- Trifluoperazine HydrochlorideExisting use: Anxiety disorder, Mental or behavioural disorder, Psychosis and 1 more84.6% AI-predicted activityagainst M. tuberculosis1 registered study
- TriclosanExisting use: Phenol and derivatives, Medicated dressings with antiinfectives84.2% AI-predicted activityagainst M. tuberculosisLab records exist50+ registered studies
- NitrofurazoneExisting use: Eye infection, Leishmaniasis, Trypanosomiasis84.0% AI-predicted activityagainst M. tuberculosis8 registered studies
- BrinzolamideExisting use: Glaucoma, Ocular hypertension, Open-angle glaucoma83.8% AI-predicted activityagainst M. tuberculosisLab records exist50+ registered studies
- ZonisamideExisting use: Epilepsy, Focal-onset seizure, Partial epilepsy and 1 more82.8% AI-predicted activityagainst M. tuberculosisLab records exist50+ registered studies
Registered studies
A registration describes a study; it does not establish a positive result.
Antagonism of Neostigmine in Continuous Infusion of Mivacurium
NCT07524959 · start 2026-05-01
Registered record
- Registry ID
- NCT07524959
- Conditions
- Neuromuscular Blocking Agents
- Interventions
- Neostigmine
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Not yet recruiting
- Start
- 2026-05-01
- Completion
- 2026-07-29
- Enrolment
- 120
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionNeuromuscular Blocking AgentsInterventionNeostigminePhaseNot applicableRegistry statusNot yet recruitingMuscle Relaxant Effect and Safety of Mivacurium Chloride and Succinylcholine for Bronchoscopy
NCT06709066 · start 2024-11-20
Registered record
- Registry ID
- NCT06709066
- Conditions
- Anesthesia; Bronchoscopy; Muscle Relaxants
- Interventions
- mivacurium chloride; succinylcholine
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Not yet recruiting
- Start
- 2024-11-20
- Completion
- 2025-12-31
- Enrolment
- 240
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionAnesthesia; Bronchoscopy; Muscle RelaxantsInterventionmivacurium chloride; succinylcholinePhaseNot applicableRegistry statusNot yet recruitingEvaluation of Effectiveness of Two Different Doses of Mivacurium in Rapid Sequence Intubation
NCT06072534 · start 2023-09-01
Registered record
- Registry ID
- NCT06072534
- Conditions
- Emergencies
- Interventions
- "Mivacurium Chloride"
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Unknown
- Start
- 2023-09-01
- Completion
- 2024-01
- Enrolment
- 100
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionEmergenciesIntervention"Mivacurium Chloride"PhaseNot applicableRegistry statusUnknownMivacurium 0.2 mg/kg in Young (18 - 40 Years) and Elderly (= 80 Years) Patients
NCT05558137 · start 2022-09-30
Registered record
- Registry ID
- NCT05558137
- Conditions
- Onset Time of Mivacurium, Duration of Action of Mivacurium
- Interventions
- Mivacurium
- Study type
- OBSERVATIONAL
- Phase
- Not recorded
- Registry status
- Completed
- Start
- 2022-09-30
- Completion
- 2023-05-25
- Enrolment
- 70
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionOnset Time of Mivacurium, Duration of Action of MivacuriumInterventionMivacuriumPhaseNot recordedRegistry statusCompleted: A Comparison of Neuromuscular Transmission in the Muscles During General Anesthesia
NCT04845386 · start 2021-03-25
Registered record
- Registry ID
- NCT04845386
- Conditions
- Neuromuscular Blockade
- Interventions
- TOF Cuff on arm; TOF Cuff on lower leg; TOF Scan on toe; TOF Scan on adductor pollicis; TOF Scan on corrugator supercilii
- Study type
- OBSERVATIONAL
- Phase
- Not recorded
- Registry status
- Completed
- Start
- 2021-03-25
- Completion
- 2021-06-30
- Enrolment
- 128
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionNeuromuscular BlockadeInterventionTOF Cuff on arm; TOF Cuff on lower leg; TOF Scan on toe; TOF Scan on adductor pollicis +1 morePhaseNot recordedRegistry statusCompletedCan we Antagonize Mivacurium With Neostigmine ?
NCT03019835 · start 2016-12
Registered record
- Registry ID
- NCT03019835
- Conditions
- Mivacurium; Neostigmine; Residual Paralysis
- Interventions
- Neostigmine (40 mcg / kg) at different time of neuromuscular block's recovery; Spontaneous recovery
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2016-12
- Completion
- 2017-04-22
- Enrolment
- 80
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionMivacurium; Neostigmine; Residual ParalysisInterventionNeostigmine (40 mcg / kg) at different time of neuromuscular block's recovery; Spontaneous recoveryPhaseNot applicableRegistry statusCompletedUse of Neuromuscular Blocking Agents and Neuromuscular Monitoring in 7 Danish Teaching Hospitals
NCT02914119 · start 2016-10-01
Registered record
- Registry ID
- NCT02914119
- Conditions
- Neuromuscular Blockade
- Interventions
- Rocuronium; Succinylcholine; Cisatracurium; Mivacurium; Objective neuromuscular monitoring (acceleromyography); Sugammadex; Neostigmine
- Study type
- OBSERVATIONAL
- Phase
- Not recorded
- Registry status
- Completed
- Start
- 2016-10-01
- Completion
- 2017-06-01
- Enrolment
- 30,430
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionNeuromuscular BlockadeInterventionRocuronium; Succinylcholine; Cisatracurium; Mivacurium +3 morePhaseNot recordedRegistry statusCompletedMivacurium Chloramine Muscle Relaxation Effect in Patients With Liver Cirrhosis
NCT02473601 · start 2014-10
Registered record
- Registry ID
- NCT02473601
- Conditions
- Liver Dysfunction
- Interventions
- Mivacurium Chloride
- Study type
- INTERVENTIONAL
- Phase
- Phase 2
- Registry status
- Unknown
- Start
- 2014-10
- Completion
- 2015-09
- Enrolment
- 80
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionLiver DysfunctionInterventionMivacurium ChloridePhasePhase 2Registry statusUnknownLow Dose Mivacurium vs. Low Dose Succinylcholine for Rigid Bronchoscopy
NCT01966484 · start 2013-10
Registered record
- Registry ID
- NCT01966484
- Conditions
- Intubating Conditions; Performance With Respiratory Exercise Device; Postoperative Myalgia
- Interventions
- Succinylcholine; Mivacurium
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2013-10
- Completion
- Not recorded
- Enrolment
- 100
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionIntubating Conditions; Performance With Respiratory Exercise Device; Postoperative MyalgiaInterventionSuccinylcholine; MivacuriumPhaseNot applicableRegistry statusCompletedSex-related Differences in the Response to the Muscle Relaxant Drug Mivacurium
NCT01906528 · start 2013-03
Registered record
- Registry ID
- NCT01906528
- Conditions
- Muscle Relaxation; Sex
- Interventions
- Mivacurium
- Study type
- INTERVENTIONAL
- Phase
- Phase 1
- Registry status
- Completed
- Start
- 2013-03
- Completion
- 2013-07
- Enrolment
- 20
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionMuscle Relaxation; SexInterventionMivacuriumPhasePhase 1Registry statusCompletedEffect of Deep BLock on Intraoperative Surgical Conditions
NCT01631149 · start 2012-06
Registered record
- Registry ID
- NCT01631149
- Conditions
- Prostate Hypertrophy; Renal Disease
- Interventions
- Surgical block (rocuronium; atracurium/mivacurium); Surgical block (rocuronium; atracurium/mivacurium)
- Study type
- INTERVENTIONAL
- Phase
- Phase 4
- Registry status
- Completed
- Start
- 2012-06
- Completion
- 2013-03
- Enrolment
- 24
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionProstate Hypertrophy; Renal DiseaseInterventionSurgical block (rocuronium; atracurium/mivacurium); Surgical block (rocuronium; atracurium/mivacurium)PhasePhase 4Registry statusCompletedA Prospective, Multi-center, Randomized Controlled Study of Muscle Relaxation Effect and Safety of Mivacurium Chloride in Pediatric Surgery Patients
NCT02117401 · start 2012-01
Registered record
- Registry ID
- NCT02117401
- Conditions
- Efficacy and Safety of Mivacurium Chloride for Pediatric Patients
- Interventions
- mivacurium chloride; midazolam; ketamine; propofol; Remifentanil
- Study type
- INTERVENTIONAL
- Phase
- Phase 4
- Registry status
- Completed
- Start
- 2012-01
- Completion
- 2013-06
- Enrolment
- 1,152
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionEfficacy and Safety of Mivacurium Chloride for Pediatric PatientsInterventionmivacurium chloride; midazolam; ketamine; propofol +1 morePhasePhase 4Registry statusCompletedInfluence of Premedication Protocols for Neonatal Endotracheal Intubation on Cerebral Oxygenation
NCT01427985 · start 2011-06
Registered record
- Registry ID
- NCT01427985
- Conditions
- Newborn; Preterm; Intubation
- Interventions
- Atropine, Fentanyl, Mivacurium; Atropine, Fentanyl, Mivacurium
- Study type
- INTERVENTIONAL
- Phase
- Phase 4
- Registry status
- Completed
- Start
- 2011-06
- Completion
- 2012-07
- Enrolment
- 24
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionNewborn; Preterm; IntubationInterventionAtropine, Fentanyl, Mivacurium; Atropine, Fentanyl, MivacuriumPhasePhase 4Registry statusCompletedIntravenous Versus Inhalational Anesthesia in Parkinson's Disease
NCT00615472 · start 2003-10
Registered record
- Registry ID
- NCT00615472
- Conditions
- Parkinson's Disease
- Interventions
- Isoflurane; Remifentanil; Propofol
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Terminated
- Start
- 2003-10
- Completion
- 2011-04
- Enrolment
- 58
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionParkinson's DiseaseInterventionIsoflurane; Remifentanil; PropofolPhaseNot applicableRegistry statusTerminated